FDA approves Fluzakura for previously treated metastatic colorectal cancer
The Food and Drug Administration (FDA) has approved Fluzakura (fruquintinib) for the treatment of some adults with metastatic colorectal cancer (mCRC), biopharmaceutical company Takeda Pharmaceutical announced in a news release. Patients are eligible for treatment with Fluzacra, an oral targeted therapy, after treatment with fluoropyrimidine, oxaliplatin, irinotecan-based chemotherapy and anti-VEGF therapy. Patients with wild-type RAS […]
Most patients treated with antibiotics for acute appendicitis do not experience recurrence
August 23, 2023 2 minute read Add topics to email alerts Receive an email when a new article is posted Enter your email address to receive emails when new articles are posted. . ” data-action=”subscribe”> Subscribe Your request could not be processed. Please try again later. If you continue to experience […]
Japan seeks approval of fruquintinib for previously treated metastatic colorectal cancer
Colorectal cancer © Stock.adobe.com A new drug application (NDA) has been submitted to Japan’s Ministry of Health, Labor and Welfare seeking approval of fruquintinib (Elnato) for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC).1 The NDA is supported by data from the Phase 3 FRESCO-2 study (NCT04322539) and results from the […]
Study suggests pain caused by gastrointestinal disorders could be treated by targeting touch receptors
Researchers have discovered that receptors responsible for our sense of touch and temperature are located in the colon, making it a potential therapeutic target for chronic pain associated with gastrointestinal disorders such as irritable bowel syndrome. Research led by Dr. Hongzhen Hu from the University of Washington and Dr. Nick Spencer from Flinders University has […]